RYTM peer analysis
Rhythm Pharmaceuticals (RYTM) against its competitors: price, today's move, 1-year return and market value side by side.
RYTM and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BIOA BioAge Labs | $5.87 | -1.18% | -24.06% | – |
| BLTE Belite Bio | $154.11 | -0.41% | 57.09% | – |
| BMEA Biomea Fusion | $0.64 | 2.68% | -51.92% | – |
| BMRN BioMarin | $53.67 | -8.27% | 3.39% | $11.33B |
| GPCR Structure Therapeutics | $20.46 | -6.42% | -36.48% | – |
| MAZE Maze Therapeutics | $30.48 | -3.18% | -8.25% | – |
| MBX MBX Biosciences | $54.34 | -2.74% | 149.38% | – |
| PTN Palatin Technologies | $5.00 | 1.42% | – | $8.90M |
| SEPN Septerna | $43.32 | -1.55% | 101.58% | – |
| VKTX Viking Therapeutics | $26.92 | -1.32% | -29.47% | $3.48B |
| RYTM Rhythm Pharmaceuticals | $93.63 | 1.15% | -16.26% | $6.37B |
- RYTM's peers: BIOA (BioAge Labs), BLTE (Belite Bio), BMEA (Biomea Fusion), BMRN (BioMarin), GPCR (Structure Therapeutics), MAZE (Maze Therapeutics), MBX (MBX Biosciences), PTN (Palatin Technologies).
Updated 2026-11-03 00:01 UTC